Company Performance Metrics
- Jee Shin: Founder and CBO
Doug Hughes: CFO (Calyxo Inc)Past Role: Neotract, CFO
Calyxo, Inc. is a medical device company focused on improving the treatment of kidney stone disease through the development of specialized technologies for urology. The company designs and commercializes solutions such as its CVAC System, which uses irrigation and vacuum aspiration to remove kidney stone fragments during minimally invasive
procedures. Its approach centers on enabling physicians to achieve more complete stone clearance while reducing the need for repeat interventions. Calyxo also supports clinical research and data generation to evaluate treatment outcomes and healthcare utilization associated with its technologies. The organization operates with an emphasis on collaboration, transparency, and accountability within its teams while addressing the broader clinical and operational challenges of kidney stone care.